Follow the 아이엠바이오로직스 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 아이엠바이오로직스 has recorded 6 public disclosures. Market capitalisation: €254.4bn. The latest transaction was filed on 12 June 2026 (Sale). Among the most active insiders: 하경식. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
아이엠바이오로직스 es una empresa de salud y farmacéutica cotizada en el mercado XKRX. Se especializa en el desarrollo de soluciones biológicas innovadoras.